Concordance of peritumoral technetium 99M colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy

被引:28
作者
Kargozaran, Hamed
Shah, Mona
Li, Yueju
Beckett, Laurel
Gandour-Edwards, Regina
Schneider, Philip D.
Ehatri, Vijay P.
机构
[1] Univ Calif Davis, Ctr Canc, Div Surg Oncol, Dept Surg, Sacramento, CA 95817 USA
[2] Univ Calif Davis, Dept Pathol, Sacramento, CA 95817 USA
[3] Univ Calif Davis, Ctr Canc, Div Surg Oncol, Dept Biostat, Sacramento, CA 95817 USA
关键词
breast cancer; sentinel lymph node; subareolar; peritumoral; blue dye; radio-colloid;
D O I
10.1016/j.jss.2007.02.054
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction. Sentinel lymph node (SLN) mapping has emerged as a less invasive method for axillary lymph node staging in patients with breast cancer. Blue dye and radioisotopes are commonly used agents to localize SLNs, but the optimal site for the injection of these agents continues to be debated. In this study, we evaluated whether subareolar injection of blue dye led to the identification of the same SLNs as peritumoral injection of technetium colloid. Methods. From March 2003 to August 2006, 124 patients with invasive breast cancer, diagnosed by core needle biopsy, were included in this study. Demographic and clinical data were abstracted from medical records. Approximately 1 h prior to surgery, all patients had peritumoral injection of 37 Mbq of Tc-99m-sulfur colloid. In the operating room, 3 to 5 mL of 1% lymphazurin was injected into the subareolar area. SLNs were categorized as radio-labeled-only, blue-only, or radio-labeled + blue. Data were analyzed with 95% exact confidence intervals, Spearman rank coefficient and kappa coefficient. Results. The mean number of SLNs identified was 1.9 (range 1-5). With the combination of two methods 122 out of 124 patients (98.4%) had successful identification of SLNs. One hundred fifteen patients (92.7%) had SLNs that were blue and 121 patients (97.6%) had radio-labeled SLNs. One hundred fourteen patients had at least one SLN that was both blue and radiolabeled, yielding a concordance rate of 91.9% (95% Cl, 0.88-0.98). Metastatic disease was identified in SLNs of 28 patients. All lymph nodes with evidence of metastasis were both blue and radio-labeled. Conclusions. Our study showed a high degree of concordance between subareolar blue dye and peritumoral radiocolloid in identification of SLNs. These results further support that the breast parenchyma and subareolar plexus drain to similar SLNs within the axilla. These two techniques can complement each other in localizing SLNs with a high success rate. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:126 / 129
页数:4
相关论文
共 28 条
[1]
Lymphatic mapping and sentinel node biopsy in the patient with breast cancer [J].
Albertini, JJ ;
Lyman, GH ;
Cox, C ;
Yeatman, T ;
Balducci, L ;
Ku, NN ;
Shivers, S ;
Berman, C ;
Wells, K ;
Rapaport, D ;
Shons, A ;
Horton, J ;
Greenberg, H ;
Nicosia, S ;
Clark, R ;
Cantor, A ;
Reintgen, DS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22) :1818-1822
[2]
Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer [J].
Bauer, TW ;
Spitz, FR ;
Callans, LS ;
Alavi, A ;
Mick, R ;
Weinstein, SP ;
Bedrosian, I ;
Fraker, DL ;
Bauer, TL ;
Czerniecki, BJ .
ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (02) :169-176
[3]
Historical perspective of lymphatic tumour spread and the emergence of the sentinel node concept [J].
Borgstein, P ;
Meijer, S .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1998, 24 (02) :85-89
[4]
Functional lymphatic anatomy for sentinel node biopsy in breast cancer - Echoes from the past and the periareolar blue method [J].
Borgstein, PJ ;
Meijer, S ;
Pijpers, RJ ;
van Diest, PJ .
ANNALS OF SURGERY, 2000, 232 (01) :81-89
[5]
Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer [J].
Burak, WE ;
Hollenbeck, ST ;
Zervos, EE ;
Hock, KL ;
Kemp, LC ;
Young, DC .
AMERICAN JOURNAL OF SURGERY, 2002, 183 (01) :23-27
[6]
Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy [J].
Chagpar, A ;
Martin, RC ;
Chao, C ;
Wong, SL ;
Edwards, MJ ;
Tuttle, T ;
McMasters, KM .
ARCHIVES OF SURGERY, 2004, 139 (06) :614-618
[7]
Factors predicting failure to identify a sentinel lymph node in breast cancer [J].
Chagpar, AB ;
Martin, RC ;
Scoggins, CR ;
Carlson, DJ ;
Laidley, AL ;
El-Eid, SE ;
McGlothin, TQ ;
Noyes, RD ;
Ley, PB ;
Tuttle, TM ;
McMasters, KM .
SURGERY, 2005, 138 (01) :56-63
[8]
ESTOURGIE SH, 2002, EJSO, V29, P336
[9]
LYMPHATIC MAPPING AND SENTINEL LYMPHADENECTOMY FOR BREAST-CANCER [J].
GIULIANO, AE ;
KIRGAN, DM ;
GUENTHER, JM ;
MORTON, DL .
ANNALS OF SURGERY, 1994, 220 (03) :391-401
[10]
A concordance study of subareolar and subdermal injections for breast cancer sentinel lymph node mapping [J].
Gray, RJ ;
Pockaj, BA .
AMERICAN JOURNAL OF SURGERY, 2004, 188 (04) :423-425